awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36026414-873699A1-B27C-4D95-8B6F-23117A0DAD4A
Q36026414-873699A1-B27C-4D95-8B6F-23117A0DAD4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36026414-873699A1-B27C-4D95-8B6F-23117A0DAD4A
The patient experience
P2860
Q36026414-873699A1-B27C-4D95-8B6F-23117A0DAD4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36026414-873699A1-B27C-4D95-8B6F-23117A0DAD4A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39a31152d8492c5fb1640038ec4351191245ab08
P2860
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3).